Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

April 6, 2026 6:01 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, its investigational seasonal influenza vaccine, and for mRESVIA® (mRNA-1345), its mRNA respiratory syncytial virus (RSV) vaccine, at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, Germany, on April 17-21, 2026.Moderna's presentation,...

Read more

NX Development Corp Submits Supplemental New Drug Application to FDA for MEN-301 Study

April 6, 2026 5:00 PM

NX Development Corp (NXDC) is pleased to announce that after successfully completing the data analysis of our MEN-301 Study of the use of Gleolan® (aminolevulinic acid HCl) to enhance visualization of newly diagnosed or recurrent meningioma, we have submitted these data to the FDA for review as part of an efficacy supplement to our Gleolan New Drug Application (NDA)."This marks the first submission of supplemental data to the FDA since our...

Read more

Emerging Growth Research Reiterates Buy-Extended Rating on SBC Medical Group Holdings, Inc. with $9.00 Price Target Following Q4:25 Quarterly Update

April 6, 2026 4:00 PM

Emerging Growth Research today announced the release of its Quarterly Update Report on SBC Medical Group Holdings, Inc. (Nasdaq:SBC), reiterating a Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's closing price of $4.47 on April 3, 2026.The Quarterly Update reflects SBC's Q4:25 financial results, ongoing business transition, and outlook for a return to revenue growth in 2026...

Read more

Revolutionary Cancer Company Oncosure Testing Announces New Non-Executive Advisory Board

April 6, 2026 12:00 PM

Advanced Oncosure Testing Inc., ("OncoSure Testing") an early detection cancer screening company focused on non-evasive, and cost efficient cancer detection announced today that it has created a new Non-Executive Advisory Board to help strategically guide the company through growth and testing protocols.In one simple blood draw, OncoSure Testing tests for Oncosomes which are microscopic, cancer-associated extracellular vesicles. By isolating and...

Read more

MyPlanAdvocate Rebrands as MPA and Integrates HealthyLabs, Bringing AI-Powered Performance Marketing In-House

April 6, 2026 10:00 AM

MyPlanAdvocate today announced its new brand identity as MPA. At the same time, the company announced the integration of HealthyLabs into MPA, bringing performance marketing and lead generation capabilities fully in-house.The combined company now unites brokerage, technology, and performance marketing under one brand at mpa.com. With the integration of HealthyLabs, MPA adds AI-driven lead scoring, multi-channel campaign management, and real-time...

Read more

Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board

April 6, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced formation of an Acute Kidney Injury (AKI) Advisory Board for the upcoming Phase 2/3 AKI clinical trial. This distinguished panel brings together internationally recognized Nephrologists and Critical Care Physicians who will guide the company's...

Read more

IAVI Begins First-in-Human Phase 1 Trial of Single-Dose Marburg Virus Vaccine Candidate

April 6, 2026 9:00 AM

No vaccines are approved specifically for the prevention of Marburg virus diseaseMarburg virus disease outbreaks seem to be increasing in frequency. Three outbreaks have occurred in sub-Saharan Africa in the past 18 months.The disease has an average case-fatality rate of about 65%.[1]Marburg virus is determined by the Department of Homeland Security to present a material threat to U.S. national security and is a Public Health Emergency Medical...

Read more

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

April 6, 2026 8:30 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) ("Sunshine Biopharma" or the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the filing of its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025.2025 HighlightsRevenue of $36.3 million, representing a 4.1% increase compared to 2024.$2.46 million in gross proceeds raised...

Read more

Infinity Chem Announces Exosomes Research Focus

April 6, 2026 8:20 AM

Infinity Chem, operating through 8chem.com, today announced an expanded research focus around exosomes and extracellular vesicle science with the release of its new feature, "Exosomes - The Future of Regenerative Science." The announcement reflects the company's broader commitment to research-use-only materials, technical transparency, and scientifically grounded content for laboratories working in regenerative science, extracellular vesicle...

Read more

MDCE's Snapshot Recipes App Scales Marketing Strategy Beyond Initial Podcast Deals with Expanded iHeart Campaign

April 6, 2026 8:15 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced the expansion of its coordinated podcast marketing campaign to drive user adoption and engagement for its AI-powered mobile application, Snapshot Recipes. The expanded campaign extends beyond previously announced agreements with "Sibling Revelry" with Kate Hudson, "Wellness Unmasked" with Dr. Nicole Saphier, and "Native Land Pod" with Angela Rye, and now includes a...

Read more

American College of Osteopathic Family Physicians Convenes Experts for Disease Prevention Summit

April 6, 2026 7:00 AM

On April 15, ACOFP, in collaboration with sponsors Sanofi and Merck, will gather 25 osteopathic family physicians in Orlando, Florida, for a focused Disease Prevention Summit. This three-hour thought leadership session will bring together clinicians from across the country to address emerging challenges in vaccine confidence, access, and disease prevention in primary care. The summit is being held in conjunction with ACOFP's 63rd Annual...

Read more

Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity

April 6, 2026 6:00 AM

As cannabis stocks rally following new federal flexibility on hemp derived CBD products, investors are asking a deeper question: which companies are actually positioned to succeed under the emerging FDA led cannabinoid regulatory framework?Cannabis equities surged this week after the U.S. Food and Drug Administration announced it would exercise enforcement discretion toward certain physician-directed hemp-derived oral CBD products participating...

Read more

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

April 6, 2026 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischner, SVP of Corp. Communication, will be presenting at the 25th Annual Needham Healthcare Conference on Tuesday, April 14, 2026, at 11:45 am ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com. This webcast...

Read more

Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration

April 6, 2026 4:00 AM

Bioz, Inc., the AI-powered citation management platform for research, announced its collaboration with Vilber, a leading manufacturer of imaging and analysis systems for molecular biology and life science laboratories. Through a highly customized Bioz Badges implementation, Vilber is enhancing scientific transparency across its digital portfolio while delivering added value to both direct customers and global distributors."Scientific credibility...

Read more

Dr. Sacha Obaid Named Among 2026 Best Doctors in Collin County

April 3, 2026 4:50 PM

Dr. Sacha Obaid of North Texas Plastic Surgery has been recognized as one of the 2026 Best Doctors in Collin County by D Magazine.This peer-selected honor identifies top doctors in the region through nominations and voting by fellow esteemed members of the local medical community. D Magazine contacts thousands of local physicians each year for confidential ballots, tallies votes, and vets results through an independent panel of physicians to...

Read more

Todd H. Lanman to Present First Full U.S. IDE Trial Results for FDA-Approved Synergy Disc(R) at ISASS 2026

April 2, 2026 7:45 PM

Following the recent FDA Premarket Approval (PMA) of the Synergy Disc®, Todd H. Lanman, MD, a pioneer in motion-preserving spine surgery, will present the first full results from the U.S. Investigational Device Exemption (IDE) clinical trial at the International Society for the Advancement of Spine Surgery (ISASS) 2026 Annual Conference in Miami Beach, April 9-11. Dr. Lanman served as a principal investigator in the multicenter U.S. IDE study...

Read more

Black Book Research Releases 2026 State of Digital Healthcare in Post-Acute Care Report as Providers Shift Spending to Reimbursement Protection, Referral Speed, Workforce Stability, and Cyber Resilience

April 2, 2026 11:45 AM

Black Book Research today announced the release of its new Q2 2026 market-intelligence report, 2026 State of Digital Healthcare in Post-Acute Care, a sector-specific analysis of technology buying patterns, market demand, regulatory pressure, operating costs, workforce constraints, financing trends, implementation realities, technology gaps, and vendor landscape coverage across skilled nursing, subacute care, home health, hospice, assisted...

Read more

AGS Health(R) Expands Data Security Portfolio with HITRUST Certification

April 2, 2026 9:30 AM

AGS Health®, a leading provider of tech-enabled RCM solutions and a strategic growth partner to healthcare providers across the U.S., announced today it has enhanced its security profile with HITRUST i1 certification for its cloud-hosted and on-premises enterprise infrastructure and SaaS applications, and the systems and platforms that support its global operations. This certification shows that AGS Health has met requirements defined by a...

Read more

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress

April 2, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that it is a silver-level sponsor of the April 2-4, 2026 Annual ELITE PED-GI Congress in Abu Dhabi in the United Arab Emirates (UAE).As previously announced, Napo is supporting an independent investigator-initiated proof-of-concept study of crofelemer liquid formulation in pediatric intestinal failure (IF) patients with in microvillus inclusion...

Read more

AIF Reaches First Close of Fund II Which Will Invest in Solutions Related to Autism, Behavioral Health and Mental Health Conditions

April 2, 2026 9:00 AM

AIF, a pioneering venture capital fund for autism, behavioral health and mental health conditions, has reached the first close of its second fund (Fund II), which will invest in solutions related to autism, behavioral health, mental health and related conditions. Launched in 2021, AIF now has approximately $150 million in assets under management with 17 portfolio companies and two successful exits from Fund I.Since its founding, AIF has...

Read more